Literature DB >> 17525135

Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB).

Jinghui Zhang1, Richard P Finney, William Rowe, Michael Edmonson, Sei Hoon Yang, Tatiana Dracheva, Jin Jen, Jeffery P Struewing, Kenneth H Buetow.   

Abstract

Systematic investigations of genetic changes in tumors are expected to lead to greatly improved understanding of cancer etiology. To meet the analytical challenges presented by such studies, we developed the Cancer Genome WorkBench (http://cgwb.nci.nih.gov), the first computational platform to integrate clinical tumor mutation profiles with the reference human genome. A novel heuristic algorithm, IndelDetector, was developed to automatically identify insertion/deletion (indel) polymorphisms as well as indel somatic mutations with high sensitivity and accuracy. It was incorporated into an automated pipeline that detects genetic alterations and annotates their effects on protein coding and 3D structure. The ability of the system to facilitate identifying genetic alterations is illustrated in three projects with publicly accessible data. Mutagenesis in tumor DNA replication leading to complex genetic changes in the EGFR kinase domain is suggested by a novel deletion-insertion combination observed in paired tumor-normal lung cancer resequencing data. Automated analysis of 152 genes resequenced by the SeattleSNPs group was able to identify 91% of the 1251 indel polymorphisms discovered by SeattleSNPs. In addition, our system discovered 518 novel indels in this data set, 451 of which were found to be valid by manual inspection of sequence traces. Our experience demonstrates that CGWB not only greatly improves the productivity and the accuracy of mutation identification, but also, through its data integration and visualization capabilities, facilitates identification of underlying genetic etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525135      PMCID: PMC1899122          DOI: 10.1101/gr.5963407

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  25 in total

1.  A space-efficient algorithm for local similarities.

Authors:  X Q Huang; R C Hardison; W Miller
Journal:  Comput Appl Biosci       Date:  1990-10

2.  Base-calling of automated sequencer traces using phred. I. Accuracy assessment.

Authors:  B Ewing; L Hillier; M C Wendl; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

3.  Consed: a graphical tool for sequence finishing.

Authors:  D Gordon; C Abajian; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

Review 4.  Cn3D: a new generation of three-dimensional molecular structure viewer.

Authors:  C W Hogue
Journal:  Trends Biochem Sci       Date:  1997-08       Impact factor: 13.807

5.  Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Authors:  S Neuhausen; T Gilewski; L Norton; T Tran; P McGuire; J Swensen; H Hampel; P Borgen; K Brown; M Skolnick; D Shattuck-Eidens; S Jhanwar; D Goldgar; K Offit
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core.

Authors:  F J Couch; B L Weber
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

7.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

8.  Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Authors:  Thomas J Lynch; Daphne W Bell; Raffaella Sordella; Sarada Gurubhagavatula; Ross A Okimoto; Brian W Brannigan; Patricia L Harris; Sara M Haserlat; Jeffrey G Supko; Frank G Haluska; David N Louis; David C Christiani; Jeff Settleman; Daniel A Haber
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts.

Authors:  C Shih; L C Padhy; M Murray; R A Weinberg
Journal:  Nature       Date:  1981-03-19       Impact factor: 49.962

View more
  17 in total

1.  Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  I-Ming Chen; Richard C Harvey; Charles G Mullighan; Julie Gastier-Foster; Walker Wharton; Huining Kang; Michael J Borowitz; Bruce M Camitta; Andrew J Carroll; Meenakshi Devidas; D Jeanette Pullen; Debbie Payne-Turner; Sarah K Tasian; Shalini Reshmi; Catherine E Cottrell; Gregory H Reaman; W Paul Bowman; William L Carroll; Mignon L Loh; Naomi J Winick; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2012-02-24       Impact factor: 22.113

2.  Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Jinghui Zhang; Charles G Mullighan; Richard C Harvey; Gang Wu; Xiang Chen; Michael Edmonson; Kenneth H Buetow; William L Carroll; I-Ming Chen; Meenakshi Devidas; Daniela S Gerhard; Mignon L Loh; Gregory H Reaman; Mary V Relling; Bruce M Camitta; W Paul Bowman; Malcolm A Smith; Cheryl L Willman; James R Downing; Stephen P Hunger
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

Review 3.  Mining Cancer Transcriptomes: Bioinformatic Tools and the Remaining Challenges.

Authors:  Thomas Milan; Brian T Wilhelm
Journal:  Mol Diagn Ther       Date:  2017-06       Impact factor: 4.074

4.  CREBBP mutations in relapsed acute lymphoblastic leukaemia.

Authors:  Charles G Mullighan; Jinghui Zhang; Lawryn H Kasper; Stephanie Lerach; Debbie Payne-Turner; Letha A Phillips; Sue L Heatley; Linda Holmfeldt; J Racquel Collins-Underwood; Jing Ma; Kenneth H Buetow; Ching-Hon Pui; Sharyn D Baker; Paul K Brindle; James R Downing
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

Review 5.  Our changing view of the genomic landscape of cancer.

Authors:  Daphne W Bell
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 6.  Comprehensive literature review and statistical considerations for microarray meta-analysis.

Authors:  George C Tseng; Debashis Ghosh; Eleanor Feingold
Journal:  Nucleic Acids Res       Date:  2012-01-19       Impact factor: 16.971

7.  Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma.

Authors:  Annemarie Greife; Judith Knievel; Teodora Ribarska; Günter Niegisch; Wolfgang A Schulz
Journal:  Clin Epigenetics       Date:  2014-11-23       Impact factor: 6.551

8.  Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer.

Authors:  Anna Díez-Villanueva; Izaskun Mallona; Miguel A Peinado
Journal:  Epigenetics Chromatin       Date:  2015-06-23       Impact factor: 4.954

9.  Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.

Authors:  Rosemary Braun; Richard Finney; Chunhua Yan; Qing-Rong Chen; Ying Hu; Michael Edmonson; Daoud Meerzaman; Kenneth Buetow
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

10.  MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data.

Authors:  Alexander Koch; Tim De Meyer; Jana Jeschke; Wim Van Criekinge
Journal:  BMC Genomics       Date:  2015-08-26       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.